FIELD: medicine, ophthalmology. SUBSTANCE: invention relates to ophthalmic drops comprising sulfated glycosaminoglycans and sodium salts physiological solution and containing interferon additionally in the following ratio of components in 1 ml: sulfated glycosaminoglycans, 50-1 000 mcg; interferon, 10 000-100 000 IU; sodium salts physiological solution, the balance. Invention provides reduction of treatment length and decrease of complications associated with cornea opacity. Drops can be used for treatment of cornea viral sicknesses. EFFECT: enhanced effectiveness of treatment. 7 cl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
OPHTHALMIC DROPS | 2000 |
|
RU2171107C1 |
OPHTHALMIC DROP "KARNOSIN" | 2001 |
|
RU2201213C1 |
OPHTHALMIC DROPS "BALARPAN" | 1997 |
|
RU2128975C1 |
PREPARATION FOR HEALING DISEASE AND DAMAGE OF CORNEA | 2000 |
|
RU2179026C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING CORNEAL EDEMAS | 2001 |
|
RU2197923C1 |
METHOD FOR REPAIRING CORNEAL ENDOTHELIUM | 2000 |
|
RU2165749C1 |
EYE DROPS FOR TREATING DRY EYE SYNDROME | 2006 |
|
RU2302231C1 |
METHOD FOR FINISHING EYE IMPLANTS AND CONTACT LENSES | 1998 |
|
RU2142257C1 |
PHARMACEUTICAL COMPOSITION FOR ANESTHESIA IN OPHTHALMOLOGY | 1999 |
|
RU2147876C1 |
METHOD OF TREATING INFLAMMATORY EYE DISEASES IN HUMAN AND ANIMALS FOR STIMULATION OF REPAIR PROCESSES AND EPITHELISATION | 2011 |
|
RU2470630C1 |
Authors
Dates
2003-01-20—Published
2001-05-30—Filed